13 found
Order:
  1.  36
    The expert patient: Valid recognition or false hope?David Badcott - 2005 - Medicine, Health Care and Philosophy 8 (2):173-178.
    Abstract.The United Kingdom Department of Health initiative on “The Expert Patient” (2001) reflects recent trends in political philosophy, ethics and health services research. The overall objective of the initiative is to encourage patients, particularly those suffering from chronic conditions to become more actively involved in decisions concerning their treatment. In doing so there would be (perhaps) an expectation of better patient compliance and (arguably) a resultant improvement in quality of life. Despite these anticipated beneficial influences on health outcomes, there may (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   13 citations  
  2.  47
    The basis and relevance of emotional dignity.David Badcott - 2003 - Medicine, Health Care and Philosophy 6 (2):123-131.
    The paper is a preliminary examination of the origin and role of psychological perception or “feeling” of dignity in human beings. Following Ayala's naturalistic account of morality, a sense of emotional dignity is seen as an outcome of processes of natural selection, cultural evolution, and above all a need for social inclusion. It is suggested that the existence of emotional dignity as part of a human species-related continuum provides an explanation of why we treat those in a persistent vegetative state, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  3.  27
    In pursuit of human dignity.David Badcott & Carlo Leget - 2013 - Medicine, Health Care and Philosophy 16 (4):933-936.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  4.  43
    Perspectives on assisted dying.David Badcott & Fuat S. Oduncu - 2010 - Medicine, Health Care and Philosophy 13 (4):351-353.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  5.  57
    Professional values in community and public health pharmacy.David Badcott - 2011 - Medicine, Health Care and Philosophy 14 (2):187-194.
    General practice (community) pharmacy as a healthcare profession is largely devoted to therapeutic treatment of individual patients whether in dispensing medically authorised prescriptions or by providing members of the public with over-the-counter advice and service for a variety of common ailments. Recently, community pharmacy has been identified as an untapped resource available to undertake important aspects of public health and in particular health promotion. In contrast to therapeutic treatment, public health primarily concerns the health of the entire population, rather than (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  6.  20
    Some causal limitations of pharmacogenetic concepts.David Badcott - 2006 - Medicine, Health Care and Philosophy 9 (3):307-316.
    Pharmacogenetics and pharmacogenomics are related facets of cutting edge therapeutic research in a field that relates pharmacological properties to the genetic characteristics of human beings. An optimistic interpretation suggests that “One-Size-Fits-All” therapeutics, whose effects can only be predicted in probabilistic terms, will give way eventually to individual tailor-made therapies with entirely predictable properties in each patient. Yet the concept of anticipating individual pharmacotherapeutic response appears to disregard some of the fundamental limitations of causal understanding in the biological world of structure–action (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  7.  29
    The Advent of the 'Personal Pill'.Rogeer Hoedemaekers, David Badcott & Bert Gordijn - 2001 - Ethical Perspectives 8 (1):50-58.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  8. Big Pharma: a former insider’s view. [REVIEW]David Badcott - 2013 - Medicine, Health Care and Philosophy 16 (2):249-264.
    There is no lack of criticisms frequently levelled against the international pharmaceutical industry (Big Pharma): excessive profits, dubious or even dishonest practices, exploiting the sick and selective use of research data. Neither is there a shortage of examples used to support such opinions. A recent book by Brody (Hooked: Ethics, the Medical Profession and the Pharmaceutical Industry, 2008) provides a précis of the main areas of criticism, adopting a twofold strategy: (1) An assumption that the special nature and human need (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  9.  51
    Assisted dying: the influence of public opinion in an increasingly diverse society. [REVIEW]David Badcott - 2010 - Medicine, Health Care and Philosophy 13 (4):389-397.
    Attitudes to questions of whether physician-assisted dying should be legalised in the UK, reflect one of the greatest challenges to moral stance in health care for both individuals and professional bodies, not least as indicated by public opinion. However, public opinion is a seductively deceptive notion, seemingly readily identifiable but in practice multifarious. At best, consensus regarding public opinion and assisted dying is illusory, sometimes transient and what is relevant in this matter is a comprehension of both majority (popular) opinion (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  10.  29
    Causal thinking and causal language in health care: Introduction to the theme. [REVIEW]David Badcott - 2006 - Medicine, Health Care and Philosophy 9 (3):269-271.
    Pharmacogenetics and pharmacogenomics are related facets of cutting edge therapeutic research in a field that relates pharmacological properties to the genetic characteristics of human beings. An optimistic interpretation suggests that “One-Size-Fits-All” therapeutics, whose effects can only be predicted in probabilistic terms, will give way eventually to individual tailor-made therapies with entirely predictable properties in each patient. Yet the concept of anticipating individual pharmacotherapeutic response appears to disregard some of the fundamental limitations of causal understanding in the biological world of structure–action (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  11.  35
    Employing patient expertise: Introduction to the theme. [REVIEW]David Badcott - 2005 - Medicine, Health Care and Philosophy 8 (2):147-148.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  12.  43
    Professional values: introduction to the theme. [REVIEW]David Badcott - 2011 - Medicine, Health Care and Philosophy 14 (2):185-186.
  13.  52
    The dominance of Big Pharma: unhealthy relationships? [REVIEW]David Badcott & Stephan Sahm - 2013 - Medicine, Health Care and Philosophy 16 (2):245-247.
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark